Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpharmatimes.com
PharmaTimes: News RSS
Get the latest updates from PharmaTimes: News RSS directly as they happen.
Follow now 135 followers
Latest posts
Last updated about 19 hours ago
Novogene Europe expands single‑cell sequencing capability in Cambridge
about 20 hours ago
New service strengthens UK access to advanced multiomics support
Lundbeck secures FDA Fast Track for narcolepsy drug
5 days ago
Designation supports development of novel orexin therapy
GSK wins US approval for ROS1 lung cancer therapy
5 days ago
Jideytro offers option for previously treated patients
Mission Therapeutics divests MTX652 to Dimerix in deal worth up to $292 million
6 days ago
Move sharpens Mission’s focus on CNS pipeline as renal specialist takes AKI...
R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia
6 days ago
First patient randomised as study advances novel pan phosphate transporter inhibitor
ViiV Healthcare to unveil new HIV treatment data at AIDS 2026
7 days ago
Company to showcase INSTI-powered innovation across treatment and PrEP
Nouscom to present re‑treatment data in Lynch Syndrome at ESMO 2026
7 days ago
Long‑term follow‑up reinforces momentum toward registration‑enabling trial
Jasper Therapeutics merges with Kira Pharmaceuticals
8 days ago
Combined company to advance biologics for immunologically‑driven disorders
EpilepsyGTx and ClearPoint Neuro join forces on targeted therapy
12 days ago
Partnership to support first‑in‑human trial of EPY201 in epilepsy
EC approves Erbitux combination for first‑line treatment of BRAF V600E‑mutant mCRC
14 days ago
Breakwater data show significant survival gains over standard chemotherapy